2 results
Approved WMOCompleted
To demonstrate the additive IOP lowering effect of SIMBRINZA (dosed BID) when added to DUOTRAV solution in subjects with open-angle glaucoma or ocular hypertension.
Approved WMOPending
This proof of principle study aims to provide the safety and feasibility of OCT in patients with primary shunt failure requiring re-intervention. Safety is defined as conducting the OCT measurement without complications caused by the OCT measurement…